申请人:Shionogi & Co., Ltd.
公开号:US20170066759A1
公开(公告)日:2017-03-09
The present invention is related to a compound represented by formula (I)
wherein R
1
is a hydrogen atom, substituted or unsubstituted alkyl, substituted or unsubstituted aromatic carbocyclyl, or the like; X is —N(R
3
)—, —O—, or —S—; Y is ═C(R
4
)—, or ═N—; Z is —N(R
7
)—, —O—, or —S—;
R
2
is substituted or unsubstituted alkyloxy, or the like, or a group represented by the following formula: —(CR
2a
R
2b
)
n
—R
2c
, wherein R
2a
is each independently a hydrogen atom, halogen, or the like; R
2b
is each independently a hydrogen atom, halogen, or the like; R
2a
and R
2b
which are attached to the same carbon atom may be taken together to form oxo, a substituted or unsubstituted non-aromatic carbocycle, or the like; two of R
2a
which are attached to the adjacent carbon atoms and/or two of R
2b
which are attached to the adjacent carbon atoms may be taken together to form a bond; R
2c
is substituted or unsubstituted aromatic carbocyclyl, or the like; n is an integer from 1 to 3;
R
3
and R
7
are each independently a hydrogen atom, substituted or unsubstituted alkyl, or the like;
R
4
and R
5
are each independently a hydrogen atom, halogen, substituted or unsubstituted alkyl, or the like;
R
6
is a hydrogen atom, halogen, substituted or unsubstituted alkyl, or the like,
or a pharmaceutically acceptable salt thereof, or a pharmaceutical composition comprising thereof.